How much does the generic version of Sotolaxib cost? Comparison of market prices and effectiveness of generic drugs

Sotorasib (AMG510, Sotorasib) is a targeted therapy drug specifically used to treat patients with non-small cell lung cancer (NSCLC) and colorectal cancer (mCRC) carrying KRAS G12C mutations. The drug has been approved in several countries and is widely used around the world. However, although the original drug is already on the market in some regions, sotorasibu has not yet been approved in China, so patients cannot purchase the drug through domestic channels and cannot enjoy medical insurance reimbursement.

With the high prices of original drugs, generic drugs have become an alternative choice for some patients. Currently, some generic drugs of sotolasibu have entered the market, especially in Southeast Asia, with relatively affordable prices. For example, the price of the 120mg, 56-tablet, generic drug Sotorasibu produced by Lucius Pharmaceutical Factory in Laos is about more than 1,000 yuan, which is much cheaper than the original drug. This price difference allows some patients to choose to purchase generic drugs to reduce their financial burden.

Although generic drugs have obvious advantages in price, their quality and efficacy are still the focus of patients. Generally speaking, the ingredients of generic drugs should be consistent with the original drugs, but there may be certain differences in preparation technology, stability, etc. As for sotoracib, although the generic drug from Laos Lucius Pharmaceutical Factory is low in price, its ingredients are similar to the original drug, and multiple clinical trials have proven that its therapeutic effect is basically equivalent to that of the original drug. This means that generic drugs can usually achieve similar efficacy to the original drugs in the treatment of KRAS G12C mutant non-small cell lung cancer, especially there is no significant difference in the basic mechanism of action of the drugs.

However, it should be noted that there may be differences in the production quality and regulatory system of generic drugs, especially for drugs that have not yet been officially launched in the country, and patients should be cautious when choosing. In order to ensure the safety and effectiveness of drugs, patients are advised to purchase them through formal channels and pay close attention to the side effects and reactions of the drugs during use, especially when there is no drug quality control.

Reference materials:https://www.lumakras.com/